Breaking News

21 hours ago: Community Picnic & Underground Railroad Program at Schubert Woods Pavilion
2 weeks ago: Park Forest’s Sandra Zoellner Retires After 21 Years of Service
2 weeks ago: Save the date for The Prairie Party at theNate
2 weeks ago: Governors State Has New Soccer Complex and New Men’s Coach
3 weeks ago: Wilmington Man’s Photo of Rare Snowy Egret Wins Forest Preserve Photo Contest

The FDA approved Kisqali for treatment of certain breast cancers (Source: PharmaTimes)

Health and Fitness

FDA Expands the Use of New Breast Cancer Drug

by eNews Park Forest on July 19, 2018

eNews Park Forest Author

More in Health and Fitness:

On Hantavirus, Park Forest Officials Urge Caution May 18, 2026
Rep. Kelly Condemns FDA Approval of Flavored E-Cigarettes May 6, 2026
Park Forest Aligns With Illinois Guidance on Childhood Vaccines Amid Federal Changes January 11, 2026

The FDA approved Kisqali for treatment of certain breast cancers — The FDA approved Kisqali for treatment of certain breast cancers (Source: PharmaTimes)